NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been
filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to
request that the court appoint you as lead plaintiff.
Mercury Systems, Inc. (NASDAQGS: MRCY)
Class Period: October 24, 2017 to April 24, 2018
Lead Plaintiff Deadline: September 10, 2018
Throughout the class period, Mercury Systems, Inc. allegedly made materially false and/or misleading statements
and/or failed to disclose that: (i) Mercury’s decision to in-source processing was adversely impacting Mercury’s operating margins
and free cash-flow generation and conversion; (ii) Mercury’s model was becoming structurally more working capital intensive; (iii)
as a result of the foregoing, Mercury’s public statements were materially false and misleading at all relevant times.
Get additional information about the MRCY lawsuit: http://www.kleinstocklaw.com/pslra-c/mercury-systems?wire=3
PolarityTE, Inc. (NASDAQ: COOL)
Class Period: March 31, 2017 to June 22, 2018
Lead Plaintiff Deadline: August 27, 2018
PolarityTE, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose the true
nature of (i) the status of Patent #14/954,335 at the time it was acquired by the Company on April 7, 2017 and the months
following; (ii) the updated status of Patent #14/954,335 after its June 4, 2018 final rejection by the United States Patent Office;
and (iii) that as a result of the foregoing, PolarityTE's publicly disseminated financial statements were materially false and
misleading.
Get additional information about the COOL lawsuit: http://www.kleinstocklaw.com/pslra-c/polarityte-inc?wire=3
Farmland Partners Inc. (NYSE: FPI)
Class Period: May 9, 2017 to July 10, 2018
Lead Plaintiff Deadline: September 10, 2018
According to the complaint, Farmland Partners Inc. allegedly made materially false and/or misleading statements
and/or failed to disclose that: (i) Farmland artificially increased its revenues by marking loans to related party tenants; (ii) as
a results of the foregoing, Farmland's Class Period revenues were overstated; and (iii) as a result, Farmland's public statements
were materially false and misleading at all relevant times.
Get additional information about the FPI lawsuit: http://www.kleinstocklaw.com/pslra-c/farmland-partners-inc?wire=3
Flex Pharma, Inc. (NASDAQ: FLKS)
Class Period: November 6, 2017 to June 12, 2018
Lead Plaintiff Deadline: August 20, 2018
During the class period, Flex Pharma, Inc. allegedly made materially false and/or misleading statements and/or
failed to disclose that: (i) the Company overstated the viability and approval prospects for its product candidate FLX-787 for the
treatment of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease; and (ii) as a result, Flex's public statements were
materially false and misleading at all relevant times. On June 13, 2018, Flex announced that it planned to halt its FLX-787 trials,
citing oral tolerability concerns observed in both studies. Flex also said that it will restructure its organization to reduce
costs, including reducing its workforce by approximately 60%, and that Flex's Board is exploring "strategic alternatives, including
the potential sale or merger of the company." Following this news, Flex stock dropped $3.14 per share, or 75.12%, to close at $1.04
on June 13, 2018.
Get additional information about the FLKS lawsuit: http://www.kleinstocklaw.com/pslra-c/flex-pharma-inc?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or
obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph
Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud
throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
